3 ms·
High interest rates have stopped way more drug development than lower or higher drug prices ever have. Between 2019 and 2022 there were like 88 biotech IPO loc
by doctorpangloss 2y ago
High interest rates have stopped way more drug development than lower or higher drug prices ever have.
Between 2019 and 2022 there were like 88 biotech IPO lockup expirations and only 3 were trading higher than post lockup for any period of time.
Macro determines the rate of risk taking. Not “details.” You simply 100% cannot have drug discovery without risk, and risk wants returns.
Should we have low rates and high inflation for the sake of more “discovery of medical techniques?” Inflation and high costs: dude, they are exactly the same thing!